Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-06-07 Sale |
2021-06-09 4:35 pm |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
1,750 | $26.35 | $46,113 | 936,801 (Indirect Direct) |
View |
| 2021-06-01 Sale |
2021-06-03 4:39 pm |
Arcutis Biotherapeutics Inc. | ARQT | CHAUDHURI BHASKAR Director |
10,000 | $27.5 | $275,000 | 901,372 (Indirect Direct) |
View |
| 2021-06-01 Sale |
2021-06-03 4:37 pm |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
2,200 | $27.09 | $59,603 | 283,967 (Indirect Direct) |
View |
| 2021-04-20 Sale(A) |
2021-05-19 6:43 pm |
Arcutis Biotherapeutics Inc. | ARQT | CHAUDHURI BHASKAR Director |
10,000 | $28.06 | $280,568 | 911,372 (Indirect Direct) |
View |
| 2021-05-07 Sale |
2021-05-11 11:47 am |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
750 | $35 | $26,250 | 937,545 (Indirect Direct) |
View |
| 2021-05-05 Sale |
2021-05-07 11:29 am |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
1,750 | $34 | $59,500 | 938,295 (Indirect Direct) |
View |
| 2021-05-03 Sale |
2021-05-05 2:05 pm |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
2,200 | $34.79 | $76,547 | 284,555 (Indirect Direct) |
View |
| 2021-04-30 Sale |
2021-05-04 3:00 pm |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
1,500 | $35 | $52,500 | 804,553 (Indirect Direct) |
View |
| 2021-04-20 Sale |
2021-04-22 8:17 pm |
Arcutis Biotherapeutics Inc. | ARQT | CHAUDHURI BHASKAR Director |
10,000 | $28.06 | $280,568 | 911,372 (Indirect Direct) |
View |
| 2021-04-05 Sale |
2021-04-06 5:30 pm |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
1,750 | $29.93 | $52,378 | 806,053 (Indirect Direct) |
View |
| 2021-04-01 Sale |
2021-04-05 5:33 pm |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
2,200 | $29.49 | $64,880 | 284,100 (Indirect Direct) |
View |
| 2021-03-22 Sale |
2021-03-24 11:33 am |
Arcutis Biotherapeutics Inc. | ARQT | CHAUDHURI BHASKAR Director |
10,000 | $31.1 | $311,021 | 921,372 (Indirect Direct) |
View |
| 2021-03-10 Sale |
2021-03-11 3:59 pm |
Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer |
1,750 | $32.9 | $57,575 | 178,018 (Indirect Direct) |
View |
| 2021-03-05 Sale |
2021-03-05 3:56 pm |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
1,750 | $30.55 | $53,463 | 907,003 (Indirect Direct) |
View |
| 2021-03-02 Sale |
2021-03-03 4:51 pm |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
2,107 | $35.19 | $74,136 | 776,853 (Indirect Direct) |
View |
| 2021-03-01 Sale |
2021-03-03 4:50 pm |
Arcutis Biotherapeutics Inc. | ARQT | OSBORNE DAVID W Chief Technical Officer |
780 | $34.57 | $26,968 | 237,253 (Direct) |
View |
| 2021-03-01 Sale |
2021-03-03 4:49 pm |
Arcutis Biotherapeutics Inc. | ARQT | Turney Patricia A. SVP, Operations |
934 | $34.52 | $32,242 | 9,271 (Direct) |
View |
| 2021-03-01 Sale |
2021-03-03 4:48 pm |
Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer |
773 | $34.2 | $26,440 | 112,390 (Indirect Direct) |
View |
| 2021-03-01 Sale |
2021-03-03 4:47 pm |
Arcutis Biotherapeutics Inc. | ARQT | Lock Kenneth A. Chief Commercial Officer |
933 | $34.2 | $31,908 | 22,167 (Direct) |
View |
| 2021-03-01 Sale |
2021-03-03 4:45 pm |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
2,200 | $34.37 | $75,610 | 283,647 (Indirect Direct) |
View |
| 2021-02-22 Sale |
2021-02-24 3:33 pm |
Arcutis Biotherapeutics Inc. | ARQT | CHAUDHURI BHASKAR Director |
10,000 | $35.52 | $355,191 | 931,372 (Indirect Direct) |
View |
| 2021-02-10 Sale |
2021-02-12 5:32 pm |
Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer |
2,750 | $35.64 | $98,010 | 158,645 (Indirect Direct) |
View |
| 2021-02-05 Sale |
2021-02-08 4:00 pm |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
10,000 | $34.29 | $342,916 | 914,452 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-06-09 Option Award |
2021-06-11 4:34 pm |
N/A 2031-06-09 |
Arcutis Biotherapeutics Inc. | ARQT | CHAUDHURI BHASKAR Director |
13,391 | $0 | 13,391 (Direct) |
View |
| 2021-06-07 Exercise |
2021-06-09 4:35 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
1,750 | $1.6806 | 936,801 (Direct) |
View |
| 2021-06-07 Exercise |
2021-06-09 4:35 pm |
N/A 2029-03-13 |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
1,750 | $0 | 936,801 (Direct) |
View |
| 2021-06-01 Exercise |
2021-06-03 4:37 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
1,171 | $1.6806 | 283,967 (Direct) |
View |
| 2021-06-01 Exercise |
2021-06-03 4:37 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
1,029 | $6.522 | 283,967 (Direct) |
View |
| 2021-06-01 Exercise |
2021-06-03 4:37 pm |
N/A 2029-03-13 |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
2,200 | $0 | 283,967 (Direct) |
View |
| 2021-05-21 Exercise |
2021-05-25 3:10 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
1,222 | $0.5802 | 267,249 (Direct) |
View |
| 2021-05-21 Exercise |
2021-05-25 3:10 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
390 | $1.6806 | 267,249 (Direct) |
View |
| 2021-05-21 Exercise |
2021-05-25 3:10 pm |
N/A 2029-03-13 |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
1,612 | $0 | 267,249 (Direct) |
View |
| 2021-05-10 Other |
2021-05-12 5:37 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Frazier Life Sciences VIII L.P. FHM LIFE SCIENCES VIII L.L.C. Heron Patrick J Topper James N FHM LIFE SCIENCES VIII L.P. 10% Owner |
2,205,132 | $0 | 10,790,280 (Direct) |
View |
| 2021-05-07 Exercise |
2021-05-11 11:47 am |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
750 | $1.6806 | 937,545 (Direct) |
View |
| 2021-05-07 Exercise |
2021-05-11 11:47 am |
N/A 2029-03-13 |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
750 | $0 | 937,545 (Direct) |
View |
| 2021-05-05 Exercise |
2021-05-07 11:29 am |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
1,607 | $1.6806 | 938,295 (Direct) |
View |
| 2021-05-05 Exercise |
2021-05-07 11:29 am |
N/A 2029-03-13 |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
1,607 | $0 | 938,295 (Direct) |
View |
| 2021-05-03 Exercise |
2021-05-05 2:05 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
1,172 | $1.6806 | 284,555 (Direct) |
View |
| 2021-05-03 Exercise |
2021-05-05 2:05 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
1,028 | $6.522 | 284,555 (Direct) |
View |
| 2021-05-03 Exercise |
2021-05-05 2:05 pm |
N/A 2029-03-13 |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
2,200 | $0 | 284,555 (Direct) |
View |
| 2021-04-16 Exercise |
2021-04-20 5:43 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
1,222 | $0.5802 | 291,198 (Direct) |
View |
| 2021-04-16 Exercise |
2021-04-20 5:43 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
1,433 | $1.6806 | 291,198 (Direct) |
View |
| 2021-04-16 Exercise |
2021-04-20 5:43 pm |
N/A 2029-03-13 |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
2,655 | $0 | 291,198 (Direct) |
View |
| 2021-04-01 Option Award |
2021-04-05 6:50 pm |
N/A 2031-04-01 |
Arcutis Biotherapeutics Inc. | ARQT | Burrows Scott L Chief Financial Officer |
23,000 | $0 | 23,000 (Direct) |
View |
Ownership |
2021-04-05 6:49 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Burrows Scott L Chief Financial Officer |
0 | $0 | 97,012 (Direct) |
View |
| 2021-04-01 Exercise |
2021-04-05 5:33 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
1,171 | $1.6806 | 284,100 (Direct) |
View |
| 2021-04-01 Exercise |
2021-04-05 5:33 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
1,029 | $6.522 | 284,100 (Direct) |
View |
| 2021-04-01 Exercise |
2021-04-05 5:33 pm |
N/A 2029-03-13 |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
2,200 | $0 | 284,100 (Direct) |
View |
| 2021-03-16 Exercise |
2021-03-18 1:59 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
1,222 | $0.5802 | 291,198 (Direct) |
View |
| 2021-03-16 Exercise |
2021-03-18 1:59 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
1,431 | $1.6806 | 291,198 (Direct) |
View |
| 2021-03-16 Exercise |
2021-03-18 1:59 pm |
N/A 2029-03-13 |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
2,653 | $0 | 291,198 (Direct) |
View |
| 2021-03-10 Exercise |
2021-03-11 3:59 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer |
500 | $1.6806 | 178,018 (Direct) |
View |
| 2021-03-10 Exercise |
2021-03-11 3:59 pm |
N/A 2029-05-14 |
Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer |
500 | $0 | 178,018 (Direct) |
View |
| 2021-03-03 Option Award |
2021-03-05 3:56 pm |
N/A 2031-03-03 |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
131,900 | $0 | 907,003 (Direct) |
View |
| 2021-03-04 Exercise |
2021-03-05 3:55 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer |
12,396 | $1.6806 | 260,770 (Direct) |
View |
| 2021-03-04 Exercise |
2021-03-05 3:55 pm |
N/A 2029-05-14 |
Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer |
12,396 | $0 | 260,770 (Direct) |
View |
| 2021-03-03 Option Award |
2021-03-05 3:55 pm |
N/A 2031-03-03 |
Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer |
38,300 | $0 | 260,770 (Direct) |
View |
| 2021-03-03 Option Award |
2021-03-05 3:54 pm |
N/A 2031-03-03 |
Arcutis Biotherapeutics Inc. | ARQT | Burnett Patrick See Remarks |
38,300 | $0 | 38,300 (Direct) |
View |
| 2021-03-03 Option Award |
2021-03-05 3:53 pm |
N/A 2031-03-03 |
Arcutis Biotherapeutics Inc. | ARQT | Lock Kenneth A. Chief Commercial Officer |
38,300 | $0 | 60,467 (Direct) |
View |
| 2021-03-03 Option Award |
2021-03-05 3:52 pm |
N/A 2031-03-03 |
Arcutis Biotherapeutics Inc. | ARQT | OSBORNE DAVID W Chief Technical Officer |
38,300 | $0 | 275,553 (Direct) |
View |
| 2021-03-03 Option Award |
2021-03-05 3:51 pm |
N/A 2031-03-03 |
Arcutis Biotherapeutics Inc. | ARQT | Turney Patricia A. SVP, Operations |
38,300 | $0 | 47,571 (Direct) |
View |
| 2021-03-01 Exercise |
2021-03-03 4:45 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
1,182 | $1.6806 | 283,647 (Direct) |
View |
| 2021-03-01 Exercise |
2021-03-03 4:45 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
1,018 | $6.522 | 283,647 (Direct) |
View |
| 2021-03-01 Exercise |
2021-03-03 4:45 pm |
N/A 2029-03-13 |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
2,200 | $0 | 283,647 (Direct) |
View |
| 2021-02-16 Exercise |
2021-02-17 8:35 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
1,222 | $0.5802 | 291,198 (Direct) |
View |
| 2021-02-16 Exercise |
2021-02-17 8:35 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
1,432 | $1.6806 | 291,198 (Direct) |
View |
| 2021-02-16 Exercise |
2021-02-17 8:35 pm |
N/A 2029-03-13 |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
2,654 | $0 | 291,198 (Direct) |
View |
| 2020-12-18 Ownership |
2021-02-16 7:29 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | OSBORNE DAVID W Chief Technical Officer |
12,500 | $0 | 238,033 (Direct) |
View |
Ownership |
2021-02-16 7:29 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | OSBORNE DAVID W Chief Technical Officer |
0 | $0 | 238,033 (Indirect) |
View |
| 2020-11-30 Ownership |
2021-02-16 6:32 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Lock Kenneth A. Chief Commercial Officer |
233 | $23.05 | 23,100 (Direct) |
View |
| 2020-05-31 Ownership |
2021-02-16 6:32 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Lock Kenneth A. Chief Commercial Officer |
1,004 | $14.45 | 23,100 (Direct) |
View |
| 2020-11-30 Ownership |
2021-02-16 6:31 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Turney Patricia A. SVP, Operations |
264 | $23.05 | 10,205 (Direct) |
View |
| 2020-05-31 Ownership |
2021-02-16 6:31 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Turney Patricia A. SVP, Operations |
941 | $14.45 | 10,205 (Direct) |
View |
| 2021-02-10 Exercise |
2021-02-12 5:32 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer |
750 | $1.6806 | 158,645 (Direct) |
View |
| 2021-02-10 Exercise |
2021-02-12 5:32 pm |
N/A 2029-05-14 |
Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer |
750 | $0 | 158,645 (Direct) |
View |
| 2021-02-05 Exercise |
2021-02-08 4:00 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
10,000 | $1.6806 | 914,452 (Direct) |
View |
| 2021-02-05 Exercise |
2021-02-08 4:00 pm |
N/A 2029-03-13 |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
10,000 | $0 | 914,452 (Direct) |
View |